OACOP
Tweet
Ross Wilkie and his team found walking frequency, depression and insomnia are #mediators of #osteoarthritis effects on #mortality. https://t.co/sXhff6moFd
All News
Dr Ai Lyn Tan
Tweet
What happens to the #muscles in patients with Giant Cell Arteritis after prolonged #steroid treatment?🤔
Find out at #EULAR2019 poster THU0605
Dr Alfuraih will explain using #ultrasound #shearwave #elastography
#muscle #imaging https://t.co/VrzfdNiE3I
Juan Ovalles, MD, PhD
Tweet
#Lupus associated genetic variants contribute to organ damage #EULAR2019 https://t.co/644BudBQyp
Alberta Hoi
Tweet
Thomas Dorner tells us not to lose hope in lupus trials, and that they are just following what is called the Kuhn cycle! https://t.co/xeaaUwfwgp #EULAR2019
Jose María Alvaro Gracia
Tweet
Genentech presenta nuevos datos sobre un nuevo tratamiento para el Lupus con afectación renal. Obinituzumab, Nueva esperanza para pacientes con nefritis lúpica! #EULAR2019 https://t.co/Jjl5zTBKGN
Mwidimi Ndosi
Tweet
Dr Ross Wilkie won one of the Best Abstract Awards at the European Congress of Rheumatology #EULAR2019. His study identified targets for reducing premature death in older people with #osteoarthritis. Great research led by health professionals. #HPR https://t.co/RZ2salIn3M https://t.co/huAilBKUCG
Medical Independent
Tweet
Co-founder and Director of dotMD Dr Ronan Kavanagh explains what was involved in choosing speakers for this year’s conference https://t.co/FFiqxje4HF @DotMDConf @RonanTKavanagh
Xabier Michelena Vegas
Tweet
Minimal Disease Activity in PsA is more challenging in women than in men. Unpublished data from the TICOPA trial presented by Dr. Laura Coates. #PsA #EULAR2019
CreakyJoints.org
Tweet
What factors are linked with fatigue in women in the first year of #RA? One #EULAR2019 study found these 4: obesity, steroid use, seronegativity, and poor sleep https://t.co/40lyEXjE2U
Alberta Hoi
Tweet
New anti-CD20 Mab Obinutuzumab just delivered positive results in its phase 2 study in lupus nephritis. We need to know more! #EULAR2019 https://t.co/Bx9OdmEtpy
Dr Irwin Lim
Tweet
Hydroxychloroquine: proposed risk factors for Retinopathy #EULAR2019 https://t.co/WkyNZ4GPVr
Stefan Siebert
Tweet
Mease: SEAM study MTX vs Etanercept in PsA.
ETA effects > MTX with no additional benefit of combination.
But some MTX benefit (note no PBO arm).
Interesting separation between MTX<ETA for PASDAS (muli domain) but not DAPSA (joints only) #Eular2019 @RheumNow https://t.co/WSUlGE7NEf
Dr Ai Lyn Tan
Tweet
#Gout patients tend not to tell doctors impact of gout on quality of life
👉🏼43% #mentalhealth
👉🏼27% impact on family
👉🏼26% relationship with partners
➡️🔟% lost job or retired due to gout
by Meulemeester #EULAR2019 https://t.co/fyrAyvpaYO
Stefan Siebert
Tweet
Mease: Filgotinib (selective JAK1i) in active PsA ph2. Promising data.
Interesting and informative way to present individual participant level data over time rather than just aggregate data - may be more useful for clinicians and patients to understand.
#EULAR2019 @RheumNow https://t.co/B0pLODWGJ9
David Liew
Tweet
So, what are we left with? Some patients get another year free of remission - that’s good. TCZ is steroid-sparing - that’s good. Still questions about longer follow-up and sequelae, and a year’s therapy doesn’t cure everyone. It’s not a panacea for all GCA ills, but it’s a start! https://t.co/6AiIQLnLFN
David Liew
Tweet
Well it’s not all she wrote when flares come along, flares can be treated - some data on how to fix them, but beware the channeling bias https://t.co/o0rwYr1Ll7
Stefan Siebert
Tweet
McInnes: Machine-learning separates out 13 clusters of PsA in RCT population (i.e. already selected).
Offers opportunities to reduce some of the massive heterogeneity in PsA to help inform biomarker studies and future precision medicine strategies. #Eular2019 @RheumNow https://t.co/h3Otp4Oq8U
Janet Pope
Tweet
For new knee inflammatory arthritis nearly 60% are in full remission at one year whereas 10% spread to progressive arthritis and 30% have persistent knee IA. Leiden Early arthritis cohort #EULAR2019 @RheumNow https://t.co/ZuLI1OCfhT https://t.co/x2Tr1tF0j6
Janet Pope
Tweet
Poster THU0687 FMF and schizo each increase mortality and worse if co-occurrence #EULAR2019 @RheumNow https://t.co/nVfiw25Lzf https://t.co/U9KELLJzVD
UCB News
Tweet
Be sure not to miss our symposium tomorrow morning: ‘The Patient Perspective: Addressing Challenges Facing Women with #axSpA and PsA’. Join us tomorrow! #EULAR2019 #psoriaticarthritis https://t.co/G0NkmblAhI
